|
US2017319652A1
|
|
Prevention and treatment of infections
|
|
US2018010182A1
|
|
Markers of alzheimers disease
|
|
US2014193440A1
|
|
Markers of alzheimers disease
|
|
AU2011202812A1
|
|
Biomarkers of resistance to HIV-infections in humans and biological applications thereof
|
|
GB0811555D0
|
|
Treatment of Alzheimer's disease
|
|
GB0604627D0
|
|
Markers for atherosclerosis
|
|
GB0522461D0
|
|
Dactyl detector
|
|
EP1723971A1
|
|
Methods and compositions for the treatment of viral diseases
|
|
GB0428301D0
|
|
Resistance genes
|
|
GB0412859D0
|
|
Markers for atherosclerosis
|
|
AU2003301319A1
|
|
Marker gene
|
|
CA2487734A1
|
|
Treatment with cytokines for alzheimer's disease
|
